Stocks of eHealth Inc. (EHTH) are poised to climb above their peers

eHealth Inc. (NASDAQ: EHTH) stock fell -2.17% on Tuesday to $5.42 against a previous-day closing price of $5.54. With 0.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.76 million shares. During the session, the Insurance Brokers company that operates in wider Financial sector, reached to the highest price of $5.59 whereas the lowest price it dropped to was $5.40. The 52-week range on EHTH shows that it touched its highest point at $23.09 and its lowest point at $2.67 during that stretch. It currently has a 1-year price target of $6.90. Beta for the stock currently stands at 0.36.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EHTH was down-trending over the past week, with a drop of -21.68%, but this was up by 4.84% over a month. Three-month performance surged to 88.85% while six-month performance fell -29.43%. The stock lost -75.52% in the past year, while it has gained 11.98% so far this year. A look at the trailing 12-month EPS for EHTH yields -6.29 with Next year EPS estimates of -2.19. For the next quarter, that number is 0.48. This implies an EPS growth rate of -372.90% for this year and 14.50% for next year.

Float and Shares Shorts:

At present, 27.35 million EHTH shares are outstanding with a float of 25.97 million shares on hand for trading. On Dec 29, 2022, short shares totaled 1.07 million, which was 3.91% higher than short shares on Nov 29, 2022. In addition to Mr. Francis Samuel Soistman Jr. as the firm’s CEO & Director, Mr. John Joseph Stelben serves as its Sr. VP & CFO.

Institutional Ownership:

Through their ownership of 72.59% of EHTH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 53.17% of EHTH, in contrast to 50.95% held by mutual funds. Shares owned by individuals account for 18.81%. As the largest shareholder in EHTH with 7.21% of the stake, Palo Alto Investors LP holds 1,977,993 shares worth 1,977,993. A second-largest stockholder of EHTH, BlackRock Fund Advisors, holds 1,576,430 shares, controlling over 5.75% of the firm’s shares. Millennium Management LLC is the third largest shareholder in EHTH, holding 1,568,549 shares or 5.72% stake. With a 2.98% stake in EHTH, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 816,369 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 2.23% of EHTH stock, is the second-largest Mutual Fund holder. It holds 610,411 shares valued at 2.95 million. Vanguard Extended Market Index Fu holds 1.25% of the stake in EHTH, owning 342,372 shares worth 1.66 million.


An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Sep 29, 2022, EHTH reported revenue of $50.41M and operating income of -$44.10M. The EBITDA in the recently reported quarter was -$37.39M and diluted EPS was -$1.65.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EHTH since 6 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With EHTH analysts setting a high price target of $16.00 and a low target of $4.00, the average target price over the next 12 months is $6.90. Based on these targets, EHTH could surge 195.2% to reach the target high and fall by -26.2% to reach the target low. Reaching the average price target will result in a growth of 27.31% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. EHTH will report FY 2022 earnings on 02/27/2024. Analysts have provided yearly estimates in a range of -$2.03 being high and -$3.89 being low. For EHTH, this leads to a yearly average estimate of -$2.96. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. eHealth Inc. surprised analysts by $0.29 when it reported -$1.17 EPS against a consensus estimate of -$1.46. The surprise factor in the prior quarter was $0.00. Based on analyst estimates, the high estimate for the next quarter is $1.22 and the low estimate is -$0.11. The average estimate for the next quarter is thus $0.48.

Summary of Insider Activity:

Insiders traded EHTH stock several times over the past three months with 2 Buys and 3 Sells. In these transactions, 230,000 shares were bought while 6,421 shares were sold. The number of buy transactions has increased to 17 while that of sell transactions has risen to 18 over the past year. The total number of shares bought during that period was 953,438 while 55,125 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *